货号: | RP10017-0.5-CN | 规格: | 0.5 mg;1 mg;10 mg | ||||||||||||||||||
品牌: | 热销产品 | 价格: | ¥ | ||||||||||||||||||
产品分类: | 特价奥特莱斯专区 | 研究领域: | |||||||||||||||||||
CAS编号: | 分子量: | ||||||||||||||||||||
分子式: | 别名: | ||||||||||||||||||||
储存条件: | 运输条件: | ||||||||||||||||||||
货期: | 应用: | ||||||||||||||||||||
说明书: | 备注: | ||||||||||||||||||||
产品描述 | |||||||||||||||||||||
维百奥生物现货库存,特价销售β-Amyloid (1-42), human ! | 产品信息 品名:β-Amyloid (1-42), human 品牌:金斯瑞 货号:A10693 规格:0.5 mg;1 mg;10 mg | 产品描述 This peptide is well suited to the quantitative determination of A 42 peptide. Alzheimer’s disease (AD) is characterized by the presence of extracellular plaques and intracellular neurofibrillary tangles (NFTs) in the brain. The major protein component of these plaques is beta amyloid peptide (A), a 40- to 43- amino-acid peptide cleaved from amyloid precursor protein by secretase (BACE) and a putative (gamma) secretase. Increased release of the ‘longer forms’ of A peptide, A 42 and A 43, which have a greater tendency to aggregate than A 40, occurs in individuals expressing certain genetic mutations, expressing certain ApoE alleles or may other, still undiscovered factors. | 产品属性
|